A detailed history of High Tower Advisors, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 5,701 shares of TMDX stock, worth $492,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,701
Previous 8,280 31.15%
Holding current value
$492,281
Previous $612,000 40.2%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$72.62 - $150.62 $187,286 - $388,448
-2,579 Reduced 31.15%
5,701 $858,000
Q1 2024

May 06, 2024

SELL
$70.86 - $89.93 $69,230 - $87,861
-977 Reduced 10.55%
8,280 $612,000
Q4 2023

Feb 12, 2024

SELL
$36.74 - $81.08 $35,637 - $78,647
-970 Reduced 9.48%
9,257 $730,000
Q3 2023

Nov 08, 2023

BUY
$53.47 - $96.07 $109,987 - $197,615
2,057 Added 25.18%
10,227 $559,000
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $162,462 - $217,654
2,453 Added 42.91%
8,170 $686,000
Q1 2023

May 11, 2023

SELL
$53.63 - $82.33 $30,729 - $47,175
-573 Reduced 9.11%
5,717 $432,000
Q4 2022

Feb 08, 2023

BUY
$39.08 - $64.29 $19,149 - $31,502
490 Added 8.45%
6,290 $388,000
Q3 2022

Nov 09, 2022

SELL
$31.56 - $55.75 $76,438 - $135,026
-2,422 Reduced 29.46%
5,800 $243,000
Q2 2022

Aug 10, 2022

SELL
$20.56 - $32.15 $21,711 - $33,950
-1,056 Reduced 11.38%
8,222 $260,000
Q1 2022

May 12, 2022

BUY
$12.58 - $26.94 $116,717 - $249,949
9,278 New
9,278 $250,000
Q4 2021

Feb 10, 2022

SELL
$19.16 - $32.68 $195,489 - $333,434
-10,203 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $1,425 - $1,898
55 Added 0.54%
10,203 $336,000
Q2 2021

Aug 06, 2021

SELL
$21.63 - $40.07 $2,747 - $5,088
-127 Reduced 1.24%
10,148 $333,000
Q1 2021

May 10, 2021

BUY
$17.75 - $47.82 $182,381 - $491,350
10,275 New
10,275 $426,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.75B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.